KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Shareholder's Equity Growth (5y) (2017 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -19.96%
Dec 31, 2025 -17.60%
Sep 30, 2025 -16.79%
Jun 30, 2025 -14.98%
Mar 31, 2025 17.05%
Dec 31, 2024 19.25%
Sep 30, 2024 22.32%
Jun 30, 2024 22.83%
Mar 31, 2024 24.81%
Dec 31, 2023 26.43%
Sep 30, 2023 43.82%
Jun 30, 2023 42.24%
Mar 31, 2023 30.22%
Dec 31, 2022 27.67%
Sep 30, 2022 66.36%
Jun 30, 2022 204.62%
Mar 31, 2022 71.64%
Dec 31, 2021 27.20%
Sep 30, 2021 70.18%
Jun 30, 2021 197.55%
Mar 31, 2021 71.17%
Dec 31, 2020 27.12%
Sep 30, 2020 181.82%
Jun 30, 2020 52.34%
Mar 31, 2020 -45.12%
Dec 31, 2019 -46.25%
Sep 30, 2019 -55.22%
Jun 30, 2019 -29.50%
Mar 31, 2019 -29.67%
Dec 31, 2018 -31.15%
Sep 30, 2018 -23.01%
Jun 30, 2018 -24.14%
Mar 31, 2018 3.74%
Dec 31, 2017 94.95%